Sanofi Consumer Healthcare India Limited

BSE: SANOFICONR544250ISIN INE0UOS01011

Healthcare
Pharmaceuticals
BSE 1000

Share price

₹3,475.50+46.70 (+1.36%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹5,241.35
52W low: ₹3,168.85
Off 52W high: -33.69%
1M return: -7.27%
3M return: -23.37%
6M return: -25.39%
1Y return: -28.70%
20D avg volume: 4,146
50 DMA: ₹3,810.16
200 DMA: ₹4,316.37

Key ratios Standalone

Market cap: ₹8,004 Cr
Current price: ₹3,475.50
52W high / low: ₹5,241.35 / ₹3,168.85
Face value: ₹10.00
P/E: 28.62
P/B: 29.32
EPS (TTM): ₹121.45
Book value / share: ₹118.54
ROE: 102.45%
ROCE: —
Operating margin: 40.33%
Net margin: 29.11%
Debt / equity: —
Net debt: —
Interest cover: 161.15
Dividend yield: 2.16%
Dividend / share (TTM): ₹75.00
Payout: 61.75%
Cash conversion cycle: —

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25
Income statement
	263.10	235.70	229.20	251.00	233.90	220.90	172.60	170.70	159.90	164.40
	4.40	6.30	5.60	4.60	3.00	5.60	5.20	5.00	4.20	0.80
	267.50	242.00	234.80	255.60	236.90	226.50	177.80	175.70	164.10	165.20
	164.80	150.10	144.10	165.10	152.80	154.20	111.00	110.00	101.70	102.00
	40.70	47.50	40.20	49.90	36.50	55.40	18.90	14.80	14.10	31.70
	11.60	16.00	18.10	6.10	26.00	4.60	33.50	18.40	14.40	—
	30.70	31.30	33.10	35.50	31.70	32.00	29.60	27.60	27.40	24.80
	0.30	0.40	0.50	0.50	0.60	0.50	0.40	0.40	3.40	0.10
	3.10	3.30	3.20	3.40	3.30	3.00	2.00	1.00	1.50	1.10
	66.30	58.80	51.10	57.40	55.40	57.50	40.20	39.10	30.70	30.50
	102.70	91.90	90.70	90.50	84.10	72.30	66.80	65.70	62.40	63.20
	0.00	0.00	0.00	0.00	0.00	6.60	0.00	-2.90	-1.20	-24.30
	102.70	91.90	90.70	90.50	84.10	78.90	66.80	62.80	61.20	38.90
	26.10	23.10	22.90	24.00	21.20	18.20	16.80	18.50	16.20	9.90
	76.60	68.80	67.80	66.50	62.90	60.70	50.00	44.30	45.00	29.00
	33.26	29.87	29.44	28.87	27.31	26.36	21.69	19.25	19.54	12.58
Key metrics
	106.10	95.60	94.40	94.40	88.00	82.40	69.20	64.20	66.10	40.10
	40.30%	40.60%	41.20%	37.60%	37.60%	37.30%	40.10%	37.60%	41.30%	24.40%
	29.10%	29.20%	29.60%	26.50%	26.90%	27.50%	29.00%	26.00%	28.10%	17.60%
	—	24.30%	—	21.70%	—	27.50%	—	—	—	—
	12.50%	6.70%	32.80%	47.00%	46.30%	34.40%	—	—	—	—
	21.80%	13.30%	35.60%	50.10%	39.80%	109.30%	—	—	—	—

Metric	TTM	FY26	FY25
Income statement
	979.00	878.40	724.50
	20.90	18.40	13.00
	999.90	896.80	737.50
	624.10	583.10	462.30
	178.30	160.70	127.40
	51.80	70.20	42.10
	130.60	128.80	102.70
	1.70	2.00	3.90
	13.00	11.70	4.50
	233.60	210.50	165.10
	375.80	313.70	275.20
	0.00	6.60	-28.40
	375.80	320.30	246.80
	96.10	80.20	65.80
	279.70	240.10	181.00
	121.44	104.27	78.59
Key metrics
	390.50	334.00	255.20
	39.89%	38.00%	35.20%
	28.57%	27.30%	25.00%
	22.67%	21.20%	—
	28.36%	32.70%	—
	—	269.80	—
	—	1.16	—
Cash flow
	—	277.40	—
	—	-7.60	—
	—	-221.90	—
	—	7.60	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +22.67%
Profit YoY (TTM): +28.36%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 71.28%

Quarter	September 2026	June 2026
Promoter %	71.28%	71.28%

Holder	Type	Holding	Previous	Change
Opella Healthcare Participations B.V.	Promoter	60.40%	60.40%	0.00%
Opal Bidco SAS	Promoter Group	10.88%	10.88%	0.00%
NIPPON LIFE INDIA TRUSTEE LTD- A/C NIPPON INDIA GROWTH MID CAP FUND	Public	5.96%	5.21%	+0.75%
ADITYA BIRLA SUN LIFE MUTUAL FUND - ADITYA BIRLA SUN LIFE CONSUMPTION FUND	Public	2.94%	—	—
HDFC LIFE INSURANCE COMPANY LIMITED	Public	2.33%	2.12%	+0.21%
ICICI PRUDENTIAL SMALLCAP FUND	Public	1.67%	1.57%	+0.10%
GENERAL INSURANCE CORPORATION OF INDIA	Public	1.30%	1.30%	0.00%
BAJAJ LIFE INSURANCE LIMITED	Public	1.09%	1.06%	+0.03%
SANOFI HISAMITSU K.K.	Promoter Group	0.00%	0.00%	0.00%
OH Singapore Pte. Ltd	Promoter Group	0.00%	0.00%	0.00%
OH Belgium NV/SA	Promoter Group	0.00%	0.00%	0.00%
SA healthcare pty Australia	Promoter Group	0.00%	0.00%	0.00%
Winthrop Pharma Tunisie	Promoter Group	0.00%	0.00%	0.00%
OH Ukraine LLC	Promoter Group	0.00%	0.00%	0.00%
OH Italy S.r.l	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Sanofi Consumer Healthcare India Limited S	8,004	3,475.50	28.62	—	+22.67% TTM	+28.36% TTM	-28.70%

Filings & corporate actions

Recent announcements

Copy of Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended 30th September 2026 is enclosed.29 Oct 2026 · Company Update / Newspaper Publication
The Board of Directors at its meeting held on Wednesday, 28th October 2026, considered and approved the Unaudited Financial Results for the quarter and nine months ended 30th September ....28 Oct 2026 · Company Update / Press Release / Media Release
Unaudited Financial Results for the quarter and nine months ended September 30, 2026 is enclosed.28 Oct 2026 · Result / Financial Results
We wish to inform you that the Board of Directors at its meeting held today, i.e. Wednesday, 28th October 2026, inter alia considered and approved the Unaudited Financial Results for the ....28 Oct 2026 · Board Meeting / Outcome of Board Meeting
Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve the Unaudited ....22 Oct 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026 is enclosed.12 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation for Closure of Trading Window.28 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Copy of Newspaper Publication of Unaudited Financial Results for the quarter and half year ended 30th June 2026 is enclosed.30 Jul 2026 · Company Update / Newspaper Publication
The Board of Directors at its meeting held on Tuesday, 28th July 2026, considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2026. In this ....28 Jul 2026 · Company Update / Press Release / Media Release
Unaudited Financial Results for the quarter and half year ended June 30, 2026 is enclosed.28 Jul 2026 · Result / Financial Results
We wish to inform you that the Board of Directors at its meeting held today, i.e. Tuesday, 28th July 2026, inter alia considered and approved the Unaudited Financial Results for the quarter ....28 Jul 2026 · Board Meeting / Outcome of Board Meeting
Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 ,inter alia, to consider and approve the Unaudited ....22 Jul 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 3oth June 2026 is enclosed.9 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Appointment of Statutory Auditor of the Company.29 Jun 2026 · Company Update / Appointment of Statutory Auditor/s
Please find eclosed Voting Results and Consolidated Scrutinizer''s Report of the 3rd Annual General Meeting held on 26th June 202629 Jun 2026 · AGM/EGM / AGM
Please find enclosed summary of proceeding of the 3rd Annual General Meeting of the Company held today.26 Jun 2026 · AGM/EGM / AGM
Intimation for Closure of Trading Window.26 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Advertisement of 3rd Annual General Meeting is enclosed.5 Jun 2026 · Company Update / Newspaper Publication
Business Responsibility and Sustainability Report for FY 2025 is enclosed.4 Jun 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Notice of 3rd AGM of the Company is enclosed4 Jun 2026 · AGM/EGM / AGM
Please find enclosed Annual Report for Financial Year 2025.4 Jun 2026 · Others / Reg. 34 (1) Annual Report
Please find enclosed copies of newspaper advertisements regarding convening of 3rd Annual General Meeting of the Company scheduled to be held on 26th June 2026, through VC/OAVM facility.2 Jun 2026 · Company Update / Newspaper Publication
The record date for payment of final dividend for FY 2025 is Friday, 19th June 202627 May 2026 · Corp. Action / Record Date
The Register of Member and Share Transfer Book of the Company will remain closed from Saturday, 20th June 2026 to Friday, 26th June 2026.27 May 2026 · Corp. Action / Book Closure
This is to inform you that the 3rd Annual General Meeting of the Company will be held on Friday, 26th June 2026 through VC/OAVM facility.27 May 2026 · AGM/EGM / AGM
Appointment of M/s. Price Waterhouse & Co Chartered Accountants LLP as the Statutory Auditors of the Company to fill the casual vacancy and hold officer for a period of 5 (five) consecutive ....25 May 2026 · Company Update / Appointment of Statutory Auditor/s
Appointment of M/s. Price Waterhouse & Co Chartered Accountants LLP as the Statutory Auditors of the Company to fill the casual vacancy and hold office for a period of 5 (five) consecutive ....25 May 2026 · Others / Outcome without intimation
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nippon India Mutual Fund5 May 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
This is to inform you that M/s. Kalyaniwalla & Mistry LLP, Chartered Accountants have tendered their resignation as Statutory Auditor of the Company with immediate effect.30 Apr 2026 · Company Update / Resignation of Statutory Auditors
Copy of Newspaper Publication of Unaudited Financial Result for the quarter ended 31st March 2026 is enclosed.30 Apr 2026 · Company Update / Newspaper Publication
The Board of Directors at its meeting held on Tuesday, 28th April 2026, considered and approved the Unaudited Financial Results for the quarter ended 31st March 2026. In this regard, please ....30 Apr 2026 · Company Update / Press Release / Media Release
Unaudited Financial Results for the quarter ended March 31, 2026 is enclosed.28 Apr 2026 · Result / Financial Results
We wish to inform you that the Board of Directors at its meeting held today i.e., Tuesday 28th April 2026, inter alia considered and approved the Unaudited Financial Results for the quarter ....28 Apr 2026 · Board Meeting / Outcome of Board Meeting
Please find enclosed Report of Scrutinizer dated 23rd April 2026 issued by M/s. MMJB & Associates LLP23 Apr 2026 · AGM/EGM / Postal Ballot
Please find enclosed Voting Results for Postal Ballot Notice dated 25th February 202623 Apr 2026 · AGM/EGM / Postal Ballot
Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2026 ,inter alia, to consider and approve the Unaudited ....23 Apr 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2026 is enclosed.9 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026 is enclosed.27 Mar 2026 · Company Update / Earnings Call Transcript
The video recording of SCHIL Institutional Investor Meet held on Tuesday, 24th March 2026 has been uploaded on the website of the Company.26 Mar 2026 · Company Update / Analyst / Investor Meet
Intimation for Closure of Trading Window25 Mar 2026 · Insider Trading / SAST / Closure of Trading Window

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 75.0000	19 Jun 2026	19 Jun 2026	—
Final Dividend - Rs. - 55.0000	17 Apr 2025	17 Apr 2025	—

Board meetings

28 Oct 2026 Board Meeting - Financial Results
28 Jul 2026 Board Meeting - Financial Results